Dr. Whitney Cheung
Academic and Professional Qualifications
MD, PhD
Service Resident, Division of Gastroenterology and Hepatology, Prince of Wales Hospital
General Information
Selected Awards
2014 NVTH (Dutch Society of Thrombosis and Hemostasis) “Award of Excellence”
Research Interests
Advanced endoscopy
Contact Information
Research Profile
Whitney Cheung is currently a service resident of the Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, New Territories East Cluster (NTEC), Hospital Authority. She graduated from the University of Amsterdam and obtained her PhD in Medicine at the University of Amsterdam in 2016. She received Gastroenterology & Hepatology training under professor Paul Fockens and professor Geert D’Haens at the Amsterdam University Medical Center, Amsterdam, the Netherlands.
Selected Publications
- Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: The PDER PAN study. Cheung YW, Barco S, Mathôt RA, van den Dool EJ, Stroobants AK, Serlie MJ, Middeldorp S, Coppens M. Thromb Res. 2017 Dec;160:76-82.
- Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Van der Hulle T, Cheung YW, Kooij S, Beenen LFM, van Bemmel T, van Es J, Faber LM, Hazelaar GM, Heringhaus C, Hofstee H, Hovens MMC, Kaasjager KAH, van Klink RCJ, Kruip MJHA, Loeffen RF, Mairuhu ATA, Middeldorp S, Nijkeuter M, van der Pol LM, Schol-Gelok S, Ten Wolde M, Klok FA, Huisman MV; YEARS study group. Lancet. 2017 Jul 15;390(10091):289-297.
- Post thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep vein thrombosis. Cheung YW, Middeldorp S, Prins MH, Pap A, Lensing AWA, Ten Cate-Hoek AJ, Villalta S, Milan M, Prandoni P. Thromb Haemost. 2016 Sep 27;116(4):733-8.
- In-vivo reversal of the anticoagulant effect of rivaroxaban with four-factor prothrombin complex concentrate. Cheung YW, Barco S, Hutten BA, Meijers JCM, Coppens M, Middeldorp S. Br J Haematol. 2016 Jan;172(2):255-6.
- In-vivo reversal of the anticoagulant effect of apixaban with four-factor prothrombin complex concentrate. Cheung YW, Barco S, Hutten BA, Meijers JCM, Middeldorp S, Coppens M. J Thromb Haemost. 2015 Oct;13(10):1799-805.
- Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis. Schulman S, Zondag M, Linkins L, Pasca S, Cheung YW, de Sancho M, Gallus A, Lecumberri R Molnar S, Ageno W, Le Gal G, Falanga A, Hulegårdh E, Ranta S, Kamphuisen P, Debourdeau P, Rigamonti V, Ortel TL, Lee A. J Thromb Haemost 2015 Jun; 13(6):1010-8.
- Biomarkers for post thrombotic syndrome: A case-control study. Bouman AC, Cheung YW, Spronk HM, Schalkwijk CG, Ten Cate H, Ten Wolde M, Ten Cate-Hoek AJ. Thromb Res. 2014 Aug;134(2):369-75.
- Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. Righini M, Van Es J, Den Exter PL, Roy PM, Verschuren F, Ghuysen A, Rutschmann OT, Sanchez O, Jaffrelot M, Trinh-Duc A, Le Gall C, Moustafa F, Principe A, Van Houten AA, Ten Wolde M, Douma RA, Hazelaar G, Erkens PM, Van Kralingen KW, Grootenboers MJ, Durian MF, Cheung YW, Meyer G, Bounameaux H, Huisman MV, Kamphuisen PW, Le Gal G. JAMA. 2014 Mar 19;311(11):1117-24.
